iPS Cells for Modelling and Treatment of Human Diseases
Sold by Biblios, Frankfurt am main, HESSE, Germany
AbeBooks Seller since September 10, 2024
New - Hardcover
Condition: New
Ships from Germany to U.S.A.
Quantity: 4 available
Add to basketSold by Biblios, Frankfurt am main, HESSE, Germany
AbeBooks Seller since September 10, 2024
Condition: New
Quantity: 4 available
Add to basketPRINT ON DEMAND pp. 422.
Seller Inventory # 18385849512
The field of reprogramming somatic cells into induced pluripotent stem cells (iPSC) has moved very quickly, from bench to bedside in just eight years since its first discovery. The best example of this is the RIKEN clinical trial this year in Japan, which will use iPSC derived retinal pigmented epithelial (RPE) cells to treat macular degeneration (MD). This is the first human disease to be tested for regeneration and repair by iPSC-derived cells and others will follow in the near future. Currently, there is an intense worldwide research effort to bring stem cell technology to the clinic for application to treat human diseases and pathologies. Human tissue diseases (including those of the lung, heart, brain, spinal cord, and muscles) drive organ bioengineering to the forefront of technology concerning cell replacement therapy. Given the critical mass of research and translational work being performed, iPSCs may very well be the cell type of choice for regenerative medicine in the future. Also, basic science questions, such as efficient differentiation protocols to the correct cell type for regenerating human tissues, the immune response of iPSC replacement therapy and genetic stability of iPSC-derived cells, are currently being investigated for future clinical applications.
"About this title" may belong to another edition of this title.
To ensure faster delivery, books may be shipped from any of the following locations Germany, the United Kingdom (UK), the United States (US), based on the buyer's address and product availability.
| Order quantity | 25 to 45 business days | 8 to 14 business days |
|---|---|---|
| First item | US$ 11.32 | US$ 21.27 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.